RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,678 | +7.1% | 31,069 | +4.6% | 0.00% | 0.0% |
| Q2 2023 | $221,836 | +15.5% | 29,697 | +3.1% | 0.00% | 0.0% |
| Q1 2023 | $192,109 | -23.6% | 28,802 | -11.7% | 0.00% | 0.0% |
| Q4 2022 | $251,431 | -18.4% | 32,611 | +12.8% | 0.00% | 0.0% |
| Q3 2022 | $308,000 | +35.7% | 28,904 | +3.4% | 0.00% | 0.0% |
| Q2 2022 | $227,000 | -16.5% | 27,950 | -26.7% | 0.00% | 0.0% |
| Q1 2022 | $272,000 | -66.7% | 38,107 | -20.0% | 0.00% | -50.0% |
| Q4 2021 | $816,000 | +308.0% | 47,649 | +769.2% | 0.00% | +100.0% |
| Q2 2021 | $200,000 | – | 5,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $16,889,000 | 37.30% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $31,958,000 | 5.87% |
| Yong Rong (HK) Asset Management Ltd | 377,000 | $8,675,000 | 5.69% |
| Samsara BioCapital, LLC | 752,939 | $17,325,000 | 2.72% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $34,728,000 | 2.04% |
| Spouting Rock Asset Management, LLC | 52,851 | $1,216,000 | 0.61% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 661,703 | $15,226,000 | 0.43% |
| Laurion Capital Management LP | 3,923,713 | $90,285,000 | 0.38% |
| Casdin Capital, LLC | 548,156 | $12,613,000 | 0.31% |
| Baillie Gifford | 22,061,374 | $507,632,000 | 0.27% |